# üîç Sparta TrackWise - Complete Technical Guide
## Enterprise Quality Management System for CMC Operations

**Version:** 1.0 Final  
**Last Updated:** December 2025  
**Target Audience:** Quality Engineers, CMC Scientists, QMS Administrators  
**Industry Focus:** Pharmaceutical & Life Sciences

---

## Table of Contents

1. [TrackWise Overview](#section-1)
2. [System Architecture](#section-2)
3. [Core Quality Modules](#section-3)
4. [CAPA Management](#section-4)
5. [Deviation Management](#section-5)
6. [Change Control](#section-6)
7. [Audit Management](#section-7)
8. [Integration & APIs](#section-8)
9. [Reporting & Analytics](#section-9)

---

<a name="section-1"></a>
## 1. TrackWise Overview

### üéØ What is Sparta TrackWise?

**TrackWise** is Sparta Systems' enterprise Quality Management System (QMS) designed for regulated industries, particularly pharmaceutical and medical device manufacturing.

**Core Capabilities:**
```
‚úÖ CAPA (Corrective & Preventive Action)
‚úÖ Deviation Management
‚úÖ Change Control
‚úÖ Audit Management (Internal & External)
‚úÖ Non-Conformance Management
‚úÖ Complaint Handling
‚úÖ Risk Management
‚úÖ Document Control (optional)
‚úÖ Training Management
‚úÖ Supplier Quality Management
```

---

### üìä TrackWise Architecture

```mermaid
graph TB
    subgraph "User Access"
        A1[Web Browser]
        A2[Mobile App]
        A3[Email Notifications]
    end
    
    subgraph "Application Layer"
        B1[Web Server - IIS]
        B2[TrackWise Application]
        B3[Workflow Engine]
        B4[Notification Engine]
        B5[Reporting Engine]
    end
    
    subgraph "Data Layer"
        C1[(SQL Server Database)]
        C2[(Document Repository)]
        C3[(Audit Trail Store)]
    end
    
    subgraph "Integration"
        D1[REST API]
        D2[SOAP Web Services]
        D3[File Import/Export]
        D4[SAP Connector]
    end
    
    A1 --> B1
    A2 --> B1
    A3 --> B4
    B1 --> B2
    B2 --> B3
    B2 --> B4
    B2 --> B5
    B2 --> C1
    B2 --> C2
    B2 --> C3
    B2 --> D1
    B2 --> D2
    B2 --> D3
    D1 --> D4
    
    style B2 fill:#E74C3C,color:#fff
    style C1 fill:#F39C12,color:#fff
```

---

<a name="section-4"></a>
## 4. CAPA Management

### üîÑ CAPA Workflow

```mermaid
stateDiagram-v2
    [*] --> Initiated
    Initiated --> Investigation: Assign
    Investigation --> Root_Cause_Analysis: Investigate
    Root_Cause_Analysis --> CAPA_Planning: RCA Complete
    CAPA_Planning --> Approval: Submit
    Approval --> CAPA_Planning: Reject
    Approval --> Implementation: Approve
    Implementation --> Verification: Complete
    Verification --> Effectiveness: Verify
    Effectiveness --> Closed: Effective
    Effectiveness --> Implementation: Not Effective
    Closed --> [*]
    
    note right of Investigation
        Gather evidence
        Interview personnel
        Review records
    end note
    
    note right of Root_Cause_Analysis
        5 Whys, Fishbone
        Identify true root cause
        Document findings
    end note
    
    note right of Effectiveness
        30-60-90 day checks
        Monitor KPIs
        Verify no recurrence
    end note
```

---

### üìã CAPA Record Structure

```yaml
CAPA Record: CAPA-2025-001

Header Information:
  CAPA Number: CAPA-2025-001
  Title: "OOS Investigation - Aspirin Assay"
  Type: Corrective Action
  Priority: High
  Status: In Implementation
  Initiator: Jane QC Analyst
  Initiation Date: 2025-01-20
  Due Date: 2025-03-20 (60 days)
  
Problem Statement:
  Description: |
    Three consecutive batches (LOT-2025-001, 002, 003) failed
    aspirin assay specification. Results: 94.2%, 94.5%, 94.8%
    (Specification: 95.0-105.0%). Trend indicates systematic issue.
  
  Impact Assessment:
    Patient Safety: Low (within therapeutic range)
    Product Quality: Medium (fails release spec)
    Regulatory: High (trend of failures)
    Business: High (3 batches on hold, $150K)
    
  Affected Products:
    - Aspirin 500mg Tablets
    - Aspirin 325mg Tablets
    
Investigation:
  Investigator: John Sr. Scientist
  Investigation Start: 2025-01-21
  Investigation End: 2025-01-28
  
  Timeline of Events:
    - 2025-01-15: Batch LOT-2025-001 tested, failed (94.2%)
    - 2025-01-17: Batch LOT-2025-002 tested, failed (94.5%)
    - 2025-01-19: Batch LOT-2025-003 tested, failed (94.8%)
    - 2025-01-20: CAPA initiated
    
  Data Collected:
    - Raw chromatograms (all batches)
    - Instrument logs (HPLC-001)
    - Standard preparation logs
    - Calibration records
    - Environmental monitoring data
    
Root Cause Analysis:
  Method: 5 Whys + Fishbone Diagram
  
  5 Whys:
    1. Why did assay fail? ‚Üí Peaks areas lower than expected
    2. Why were peak areas low? ‚Üí Detector response decreased
    3. Why did response decrease? ‚Üí Lamp intensity degraded
    4. Why did lamp degrade? ‚Üí Exceeded recommended usage hours
    5. Why was lamp not replaced? ‚Üí PM schedule not followed
    
  Root Cause: 
    "HPLC UV lamp exceeded 2,000 hour usage limit (actual: 2,450 hrs)
     due to missed preventive maintenance. Lamp intensity decreased
     by 15%, causing artificially low assay results."
  
  Evidence:
    - Lamp log shows 2,450 hours usage
    - PM schedule shows missed maintenance (due 12/15/24)
    - Lamp intensity check: 75% of specification (should be >90%)
    - Retest with new lamp: All batches pass (98.5%, 98.8%, 99.1%)
    
Corrective Actions:
  CA-001:
    Description: "Replace UV lamp immediately"
    Owner: QC Supervisor
    Due Date: 2025-01-22
    Status: Complete
    Completion Date: 2025-01-21
    Evidence: Work order #12345, new lamp serial #UV-2025-001
    
  CA-002:
    Description: "Retest all affected batches with new lamp"
    Owner: QC Analyst
    Due Date: 2025-01-25
    Status: Complete
    Completion Date: 2025-01-23
    Evidence: COA showing passing results
    
Preventive Actions:
  PA-001:
    Description: "Implement automated PM alerts in CMMS"
    Owner: IT Manager
    Due Date: 2025-02-15
    Status: In Progress (75%)
    Details: |
      - Email alerts at 1,800 hours (90% of limit)
      - Mandatory work order creation at 1,900 hours
      - System lock at 2,000 hours (cannot use instrument)
    
  PA-002:
    Description: "Quarterly review of all PM schedules"
    Owner: QA Manager
    Due Date: Ongoing (Start 2025-03-01)
    Status: Planned
    Frequency: Quarterly
    
  PA-003:
    Description: "Update SOP to include lamp intensity check"
    Owner: QC Manager
    Due Date: 2025-02-28
    Status: In Progress
    Document: SOP-QC-HPLC-001 (Rev 4.0)
    
Verification:
  Verification Plan:
    - Verify CA-001: Lamp installed correctly
    - Verify CA-002: Retesting complete, results documented
    - Verify PA-001: System tested with mock PM due dates
    - Verify PA-002: Calendar entries created
    - Verify PA-003: SOP updated and effective
    
  Verification Status: In Progress
  Verified By: [Pending]
  
Effectiveness Check:
  Schedule:
    - 30-day check: 2025-02-20
    - 60-day check: 2025-03-20
    - 90-day check: 2025-04-20
    
  Metrics to Monitor:
    - HPLC assay OOS rate (target: 0%)
    - PM completion on-time rate (target: 100%)
    - Lamp hours at replacement (target: <2,000)
    
  30-Day Check Results: [Pending]
  60-Day Check Results: [Pending]
  90-Day Check Results: [Pending]
  
Approvals:
  Investigation Approved:
    Approver: QA Manager
    Date: 2025-01-28
    Signature: [E-Sign]
    
  CAPA Plan Approved:
    Approver: Quality Director
    Date: 2025-01-30
    Signature: [E-Sign]
    
Linked Records:
  - Deviations: DEV-2025-005, DEV-2025-006, DEV-2025-007
  - Change Controls: CHG-2025-023 (SOP update)
  - OOS Investigations: OOS-2025-001, 002, 003
  - Training: TRN-2025-045 (Updated SOP training)
```

---

<a name="section-5"></a>
## 5. Deviation Management

### üö® Deviation Workflow

```mermaid
sequenceDiagram
    participant Operator
    participant TW as TrackWise
    participant Sup as Supervisor
    participant QA as QA Reviewer
    participant Invest as Investigator
    participant QAM as QA Manager
    
    Operator->>TW: Report Deviation
    Note over Operator,TW: Event: Temperature excursion<br/>Equipment: Incubator INC-001
    
    TW->>Sup: Notification: New Deviation
    Sup->>TW: Review & Classify
    Note over Sup,TW: Severity: Major<br/>GxP Impact: Yes
    
    Sup->>TW: Assign Investigator
    TW->>Invest: Task: Investigation
    
    Invest->>TW: Document Investigation
    Note over Invest,TW: Root Cause: Thermostat failure<br/>Duration: 2 hours<br/>Impact: 1 batch affected
    
    Invest->>TW: Propose Disposition
    Note over Invest,TW: Batch LOT-2025-005: REJECT<br/>Reason: Outside validated range
    
    TW->>QA: Review Investigation
    QA->>TW: Request Additional Testing
    
    Invest->>TW: Complete Additional Tests
    Note over Invest,TW: Potency test: 92% (spec: 90-110%)<br/>Impurities: Within limits
    
    QA->>TW: Approve Investigation
    
    TW->>QAM: Final Disposition
    QAM->>TW: Disposition: REJECT batch
    QAM->>TW: CAPA Required: Yes
    
    TW->>TW: Auto-create CAPA
    TW->>TW: Close Deviation
```

---

<a name="section-6"></a>
## 6. Change Control

### üîÑ Change Control Process

```mermaid
graph TD
    Start([Initiate Change]) --> A{Change Type?}
    
    A -->|Standard| B1[Auto-Approved]
    A -->|Minor| B2[Fast Track]
    A -->|Major| B3[Full Assessment]
    
    B1 --> C1[Implement]
    
    B2 --> D1[QA Review]
    D1 --> E1{Approved?}
    E1 -->|Yes| C1
    E1 -->|No| F1[Reject]
    
    B3 --> D2[Impact Assessment]
    D2 --> D3[Risk Assessment]
    D3 --> D4[Testing Plan]
    D4 --> D5[CAB Review]
    D5 --> E2{Approved?}
    
    E2 -->|No| F1
    E2 -->|Yes| C2[Testing]
    
    C2 --> G1[Execute Tests]
    G1 --> G2{Pass?}
    G2 -->|No| H1[Investigate]
    H1 --> C2
    G2 -->|Yes| C1
    
    C1 --> I[Implementation]
    I --> J[Verification]
    J --> K[Effectiveness]
    K --> L{Effective?}
    L -->|No| I
    L -->|Yes| M([Close])
    
    F1 --> M
    
    style Start fill:#3498DB,color:#fff
    style M fill:#2ECC71,color:#fff
    style F1 fill:#E74C3C,color:#fff
```

---

## üìä TrackWise Reporting

### Standard Reports

```yaml
Quality Metrics Dashboard:
  
  CAPA Metrics:
    - Open CAPAs by Age: >30 days (15), >60 days (5), >90 days (2)
    - CAPA Closure Rate: 85% on-time (Target: >90%)
    - Average Time to Close: 45 days (Target: <60 days)
    - CAPAs by Root Cause: Human Error (35%), Equipment (25%), Process (20%)
    
  Deviation Metrics:
    - Deviations by Month: Jan (45), Feb (38), Mar (42)
    - Deviation Trend: Stable (no significant increase)
    - Major Deviations: 8 (Target: <10/month)
    - Time to Investigation: 3.2 days avg (Target: <5 days)
    
  Change Control Metrics:
    - Changes Implemented: 25 (This month)
    - Change Success Rate: 96% (Target: >95%)
    - Average Approval Time: 12 days (Target: <15 days)
    - Emergency Changes: 2 (Target: <5%)
    
  Audit Metrics:
    - Internal Audits Complete: 12/12 (100%)
    - Findings by Severity: Critical (0), Major (5), Minor (18)
    - Finding Closure Rate: 92% (Target: >90%)
    - Overdue Findings: 3 (Target: 0)
```

---

## üéâ Conclusion

TrackWise provides:

‚úÖ **Comprehensive QMS** for CMC operations  
‚úÖ **Integrated quality modules** (CAPA, Deviation, Change)  
‚úÖ **Workflow automation** reduces manual effort  
‚úÖ **Complete audit trail** for compliance  
‚úÖ **Robust reporting** for metrics & trends  
‚úÖ **Configurable** to company processes  

**Market Position:** Leading QMS in pharma  
**Typical Implementation:** 9-12 months  
**User Base:** 500+ pharma companies globally  

---

**End of TrackWise QMS Guide**
